Telogen Effluvium: A Review

Overview

Journal J Clin Diagn Res

Specialty General Medicine

Date 2015 Oct 27

PMID 26500992

Citations 56

Authors

Shashikant Malkud

Affiliations

Soon will be listed here.

Abstract

Telogen effluvium was first described by Kligman in 1961. It is a most common cause of diffuse hair loss. Women with telogen effluvium more frequently present to dermatologist. A wide variety of potential triggers have been implicated in the pathogenesis of telogen effluvium. Diffuse shedding of telogen hair are seen after 3-4 months of triggering event. The observation of increased telogen hair shedding does not infer a cause. Establishing aetiology of telogen effluvium requires elicitation of relevant history and appropriate laboratory investigations to exclude endocrine, nutritional and autoimmune disorders.

Citing Articles

Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications.

Salazar J, Ortega A, Perez J, Garrido B, Santeliz R, Galban N Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006060 PMC: 11859979. DOI: 10.3390/ph18020247.

Human-Centric, Three Dimensional Micro Light-Emitting Diodes for Cosmetic and Medical Phototherapy.

Nam K, Kim M, An J, Min S, Lee J, Park J Adv Sci (Weinh). 2025; 12(10):e2416716.

PMID: 39960366 PMC: 11905057. DOI: 10.1002/advs.202416716.

A Well-Tolerated Hair Serum Containing New Natural Active Ingredients Reduced Hair Loss and Improved Quality of Life in Women With Chronic Telogen Effluvium: A 16-Week Controlled Study.

Turlier V, Froliger M, Ribet V, Mengeaud V, Reygagne P J Cosmet Dermatol. 2024; 23 Suppl 5:12-21.

PMID: 39606909 PMC: 11603399. DOI: 10.1111/jocd.16656.

Telogen Effluvium Following the Treatment of Euglycemic Diabetic Ketoacidosis in a Patient With Heavy Soft Drink Intake: A Case Report.

Yoshino Y, Hayashi M Cureus. 2024; 16(10):e71863.

PMID: 39559606 PMC: 11572685. DOI: 10.7759/cureus.71863.

Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation.

El-Tatawy R, Gheida S, Soliman G, Ismail M Int J Trichology. 2024; 15(5):183-190.

PMID: 39170090 PMC: 11335050. DOI: 10.4103/ijt.ijt_92_22.

References

Bottomley S . Secondary iron overload disorders. Semin Hematol. 1998; 35(1):77-86. View

Kantor J, Kessler L, Brooks D, Cotsarelis G . Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol. 2004; 121(5):985-8. DOI: 10.1046/j.1523-1747.2003.12540.x. View

Harrison S, Sinclair R . Telogen effluvium. Clin Exp Dermatol. 2002; 27(5):389-5. DOI: 10.1046/j.1365-2230.2002.01080.x. View

Bergfeld W, Mulinari-Brenner F . Shedding: how to manage a common cause of hair loss. Cleve Clin J Med. 2001; 68(3):256-61. DOI: 10.3949/ccjm.68.3.256. View

Whiting D . Chronic telogen effluvium. Dermatol Clin. 1996; 14(4):723-31. DOI: 10.1016/s0733-8635(05)70398-3. View

Shrivastava S . Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009; 75(1):20-7. DOI: 10.4103/0378-6323.45215. View

Umbreit J . Iron deficiency: a concise review. Am J Hematol. 2005; 78(3):225-31. DOI: 10.1002/ajh.20249. View

McMichael A . Approach to office visits for hair loss in women. Cutis. 2011; 87(1):8-9. View

Trost L, Bergfeld W, Calogeras E . The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006; 54(5):824-44. DOI: 10.1016/j.jaad.2005.11.1104. View

10.

Jain V, Kataria U, Dayal S . Study of diffuse alopecia in females. Indian J Dermatol Venereol Leprol. 2010; 66(2):65-8. View

11.

Chartier M, Hoss D, Grant-Kels J . Approach to the adult female patient with diffuse nonscarring alopecia. J Am Acad Dermatol. 2002; 47(6):809-18; quiz 818-20. DOI: 10.1067/mjd.2002.128771. View

12.

Paus R, Cotsarelis G . The biology of hair follicles. N Engl J Med. 1999; 341(7):491-7. DOI: 10.1056/NEJM199908123410706. View

13.

Dhurat R, Saraogi P . Hair evaluation methods: merits and demerits. Int J Trichology. 2010; 1(2):108-19. PMC: 2938572. DOI: 10.4103/0974-7753.58553. View

14.

Harrison S, Bergfeld W . Diffuse hair loss: its triggers and management. Cleve Clin J Med. 2009; 76(6):361-7. DOI: 10.3949/ccjm.76a.08080. View

15.

Dinh Q, Sinclair R . Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007; 2(2):189-99. PMC: 2684510. View

16.

Sinclair R . Diffuse hair loss. Int J Dermatol. 1999; 38 Suppl 1:8-18. DOI: 10.1046/j.1365-4362.1999.00003.x. View

17.

Buhl A . Minoxidil's action in hair follicles. J Invest Dermatol. 1991; 96(5):73S-74S. DOI: 10.1111/1523-1747.ep12471911. View

18.

Sinclair R . There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol. 2002; 147(5):982-4. DOI: 10.1046/j.1365-2133.2002.04997.x. View

19.

Hunt N, McHale S . The psychological impact of alopecia. BMJ. 2005; 331(7522):951-3. PMC: 1261195. DOI: 10.1136/bmj.331.7522.951. View